AMIKACIN solution for injection

AMIKACIN solution for injection
Product Description

Strength: 500 mg/2 ml Presentation: vials, 2 ml Therapeutic area: Anti-infective Innovator: Briklin 

Rafarm S.A

  • GR
  • 2015
    On CPHI since

Rafarm S.A

  • GR
  • 2015
    On CPHI since

More Products from Rafarm S.A (38)

  • TRAVOPROST eye drops solution

    Product TRAVOPROST eye drops solution

    Strength: 40 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Travatan (Alcon-Novartis)
  • ZOLEDRONIC ACID concentrate solution for infusion

    Product ZOLEDRONIC ACID concentrate solution for infusion

    Strength: 4 mg/5 ml Presentation: vials, 5 ml Therapeutic area: Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia Innovator: Zometa (Novartis)
  • ROSUVASTATIN CALCIUM f.c. tablets

    Product ROSUVASTATIN CALCIUM f.c. tablets

    Strength: 5 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Events Innovator: Crestor (AstraZeneca)
  • TOBRAMYCIN eye drops solution

    Product TOBRAMYCIN eye drops solution

     Strength: 3 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Infections Innovator: Tobrex (Alcon)
  • MOXIFLOXACIN HYDROCHLORIDE eye drops solution

    Product MOXIFLOXACIN HYDROCHLORIDE eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Conjunctivitis Innovator: Moxivig (Novartis)
  • CLOPIDOGREL BESILATE f.c. tablets

    Product CLOPIDOGREL BESILATE f.c. tablets

    Strength: 75 mg/tab Therapeutic area: Anti-thrombotic Innovator: Plavix (Sanofi-Aventis)
  • ATORVASTATIN f.c. tablets

    Product ATORVASTATIN f.c. tablets

    Strength: 10 mg/tab; 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Diseases Innovator: Lipitor (Pfizer)
  • BIMATOPROST + TIMOLOL eye drops solution

    Product BIMATOPROST + TIMOLOL eye drops solution

    Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan)
  • BIMATOPROST eye drops solution

    Product BIMATOPROST eye drops solution

    Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan)
  • BRIMONIDINE + TIMOLOL eye drops solution

    Product BRIMONIDINE + TIMOLOL eye drops solution

    Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan)
  • BRIMONIDINE eye drops solution

    Product BRIMONIDINE eye drops solution

    Strength: 2 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Alphagan (Allergan)
  • DEXAMETHASONE PRESERVATIVE FREE eye drops solution

    Product DEXAMETHASONE PRESERVATIVE FREE eye drops solution

    Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Treatment of inflammatory conditions of the anterior segment of the eye Innovator: Dexafree (Laboratoires THEA)